AKT1 and viral infectious disease: Individually, IFNβ pretreatment or OAS2 re-expression could specifically protect cells expressing MYC and AKT oncogenes from viral infection, suggesting oncogene-driven suppression of antiviral defense pathways increases viral susceptibility.